-
Mashup Score: 3Online Event - 3 hour(s) ago
About five million people in the United States alone live with traumatic brain injuries (TBIs). These injuries can quadruple the risk of developing Alzheimer’s disease, and other dementias, and increase the likelihood of developing neurodegenerative diseases such as amyotrophic lateral sclerosis. Rodent models of TBI have clarified some aspects of these injuries; however, most treatment approaches have had limited success because some of the details of the underlying mechanisms are still unclear. In this
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 16Online Event - 2 day(s) ago
Quantitative real-time PCR (qPCR) and digital PCR (dPCR) are powerful molecular biology techniques for quantifying and analyzing DNA or RNA, but they differ in their approach and applications. Traditional qPCR is widely used for detecting and quantifying highly specific DNA or RNA sequences in a range of research and clinical diagnostic applications. However, dPCR technology offers greater precision and sensitivity than qPCR, and is designed to handle tasks requiring precise quantification. In this GEN
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 16Online Event - 3 day(s) ago
New tools and platforms to accelerate vaccine development and manufacturing are in high demand and short supply. InDevR’s VaxArray Platform is a microarray-based system for multiplexed analysis, with a wide range of applications in vaccine analytics including identity testing, antigen quantification, serum antibody quantification, nucleic acid vaccine construct characterization, and cell-based potency. In this webinar, Dr. Kopcho will demonstrate the flexibility of the VaxArray platform through a variety
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 7Online Event - 4 day(s) ago
Workflow design and data management are pivotal components of cell and gene therapy research and development. Advances in artificial intelligence, informatics, and automation have made it possible to optimize experimental design, automate laboratory workflows, simplify process configurations, manage data, and accelerate analysis in cell and gene therapy research and development. These technological advancements are speeding up research into new therapies and enhancing the precision and reliability of
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 10Online Event - 5 day(s) ago
Gene therapy has undergone a renaissance in recent years, with several drugs offering beneficial, even life-saving treatments, now approved by the FDA. One example was reported earlier this year, with the progress made by two separate research teams working on gene therapy programs targeting hearing loss. And the FDA has stated that they expect an increase in the number of authorizations of gene therapy treatments over the next few years. But getting gene therapies into patients is a challenging road. On
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet-
New GEN Live! On 4/24, we will discuss the state of gene therapy today, the promises and pitfalls of delivery vectors, the challenge posed by the immune response, and the safety issues that need to be addressed going forward. REGISTER: https://t.co/cR7OYroiD6 @ElegenBio #CRISPRs https://t.co/zzajirU2Qi
-
-
Mashup Score: 8Online Event - 6 day(s) ago
The interest in the use of organoids to model human development in health and disease is at an all-time high. Recently, a team from the U.K. demonstrated that progenitor cells from amniotic fluid, referred to as tissue specific stem cells (and are distinct from pluripotent stem cells), can form fetal organoids. The researchers successfully developed organoids of multiple different tissue types (small intestine, kidney, and lung) from the cells collected from the amniotic fluid samples, without accessing
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 3Online Event - 7 day(s) ago
For most malignancies, early tumor detection is crucial, as it expands treatment options, reduces metastases, and ultimately improves survival rates. Despite clear clinical appeal, early detection remains a considerable diagnostic challenge since small masses of tumors often remain asymptomatic and are difficult to discern from normal tissue by imaging methods. In this GEN webinar, Nebojsa Janjic, PhD, will discuss the need for a reliable blood-based screening method capable of detecting cancers earlier.
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 10Online Event - 8 day(s) ago
Gene therapy has undergone a renaissance in recent years, with several drugs offering beneficial, even life-saving treatments, now approved by the FDA. One example was reported earlier this year, with the progress made by two separate research teams working on gene therapy programs targeting hearing loss. And the FDA has stated that they expect an increase in the number of authorizations of gene therapy treatments over the next few years. But getting gene therapies into patients is a challenging road. On
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet-
New GEN Live! On 4/24, we will discuss the state of gene therapy today, the promises and pitfalls of delivery vectors, the challenge posed by the immune response, and the safety issues that need to be addressed going forward. REGISTER: https://t.co/cR7OYroiD6 @ElegenBio #CRISPRs https://t.co/zzajirU2Qi
-
-
Mashup Score: 8Online Event - 9 day(s) ago
The interest in the use of organoids to model human development in health and disease is at an all-time high. Recently, a team from the U.K. demonstrated that progenitor cells from amniotic fluid, referred to as tissue specific stem cells (and are distinct from pluripotent stem cells), can form fetal organoids. The researchers successfully developed organoids of multiple different tissue types (small intestine, kidney, and lung) from the cells collected from the amniotic fluid samples, without accessing
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 7Online Event - 11 day(s) ago
Workflow design and data management are pivotal components of cell and gene therapy research and development. Advances in artificial intelligence, informatics, and automation have made it possible to optimize experimental design, automate laboratory workflows, simplify process configurations, manage data, and accelerate analysis in cell and gene therapy research and development. These technological advancements are speeding up research into new therapies and enhancing the precision and reliability of
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
New webinar! On 5/17, Justin Ichida, PhD, discusses using organoids to clear up the causes of neuronal damage following TBIs and ways of mitigating injury risks. REGISTER: https://t.co/DzRdLOKi5f @moldev #CancerResearch #AnimalModels #ImageAnalysis #PhenotypicScreening https://t.co/lDeCh71dXL